January 20, 2009
Press Release no.1
Recommencement of trading pursuant to
scheme of capital reduction - NEOCURE
The trading in equity
shares of Neocure Therapeutics Ltd shall be recommenced on the Exchange
pursuant to scheme of capital reduction w.e.f. January 22, 2009. Trading shall
be in the Normal Market Segment – Compulsory Demat (Rolling Settlement) for all
investors.
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
1 |
NEOCURE |
Neocure Therapeutics Ltd |
INE695B01025 |
Press Release no.2
NSE completes its 2229th
Normal Settlement
The Exchange has successfully
completed its 2229th
Normal Settlements (Rolling T+2 following SEBI
directive) since inception i.e., Settlement Numbers N – 2009011 on Jan 20,
2009. The settlement statistics is as follows:
Particulars
|
Values
|
|
N-2009011
|
Total traded quantity
(lakhs) |
6084.73 |
Total traded value (Rs. In
Crores) |
7267.62 |
Total value of the
settlement (Securities) (Rs. In Crores) |
1396.93 |
Total value of the
settlement (Funds) (Rs. In Crores) |
528.18 |
Shortages
for the settlement
|
0.13% |
% of Delivery ( No. of shares deliverable / No.
of shares traded ) |
18.51% |
Retail Debt Market have completed its 1503rd
settlements detail of which are as follows:
Settlement No. |
Traded Value |
Settlement Value |
|
|
|
Securities |
Funds |
D- 2009011 |
NIL |
NIL |
NIL |